Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication by Ming, Long et al.
LETTER TO THE EDITOR Open Access
Circulating vaccine-derived poliovirus: a
menace to the end game of polio
eradication
Long Chiau Ming1* , Zahid Hussain2, Siang Fei Yeoh3, David Koh1,4 and Kah Seng Lee5
Abstract
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio
outbreak involving 305 cases occurred in Indonesia in 2006. It was not until 2014 that the World Health
Organisation South East Asia region was officially declared polio-free again. However, in February 2019, the Global
Polio Eradication Initiative announced a new circulating vaccine-derived poliovirus outbreak in the Papua province
of Indonesia. To make matter worse, the outbreak responses were tardy and led to transmission among migrating
communities to other cities. The pressing regional issues of polio outbreak caused by circulating vaccine-derived
poliovirus and use of oral polio vaccine have not been well presented. Our letter highlighted the suboptimal
outbreak responses as well as the necessity of cross-border vaccination to curb continued poliovirus transmission.
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Until recently, there had been no reported cases of polio
since 1978 in Brunei [1], since 1992 in Malaysia and
since 1993 in the Philippines [2]. The World Health
Organization (WHO) Western Pacific Region countries
were declared free of polio in 2000 until a polio outbreak
involving 305 cases occurred in Indonesia in 2006 [3].
However, in 2019, polio re-emerged in three countries
in the Western Pacific region. The Global Polio Eradica-
tion Initiative announced a new circulating vaccine-
derived poliovirus (cVDPV) outbreak in Papua,
Indonesia in Feb 2019. In September 2019, a national
polio outbreak was declared in the Philippines [4]. Sub-
sequently, on December 6, 2019, the WHO’s Polio Re-
gional Laboratory in Australia verified that the sample
taken from an infant from the Malaysia Borneo state of
Sabah was infected with cVDPV which had a direct link
to the polio virus detected in the acute flaccid paralysis
cases reported in the neighboring Filipino island of
Mindanao [4].
Main cause of re-emergence
cVDPV remains a menace to the end game of polio
eradication as it is one of the main causes of re-
emerging polio apart from vaccination refusal. cVDPV
originates from the oral polio vaccine. This weakened
virus is excreted by the body through feces which could
spread easily in a non-sanitary environment. In the early
2000s, in order to avoid the risk of cVDPV posed by the
weakened poliovirus transmitted through oral polio vac-
cine (OPV), inactivated polio vaccine (IPV) was strongly
advocated. By June 2018, 39 of 47 African countries had
changed from OPV to IPV. In spite of that, sporadic
cases of cVDPVs were spotted in countries using OPV
with low population immunity [5]. For example, in 2018,
cVDPV outbreaks were reported in Nigeria, Kenya and
the Democratic Republic of the Congo,
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Another approach to totally eliminate the risk of re-
emergence of wild poliovirus type-2, is to utilize bivalent
OPV that contains Sabin serotypes 1 and 3 strains, in-
stead of trivalent OPV that contains Sabin strains of all
three poliovirus serotypes [6].{Regional Committee for
Africa (68), 2018 #6} Drastic measures were taken when
all member states in the WHO African Region withdrew
trivalent OPV in May 2016 [5]. In Southeast Asia, Brunei
and Malaysia has fully utilized the IPV but the trivalent
OPV is still used in the Philippines and Indonesia with
the latter introducing IPV in the national immunization
program from July 2016 [7]. Furthermore, the use of
monovalent type-2 polio vaccine in response to cVDPV
Type-2 outbreaks poses the risk of the emergence of
“de-novo” cVDPV Type-2 [8].
Besides the use of IPV or bivalent OPV, a comprehen-
sive vaccine coverage is essential. Even though in general
Brunei and Malaysia had achieved more than 95%
immunization rates, approximately 12% of the children
living in the affected sites on the coastal region of Sabah
were not vaccinated, putting the whole community at
risk of losing the vital herd immunity. The situation is
heterogenous as across the South China Sea, the
immunization rate among 105 million residents in the
Philippines stood at 66 and 41% for OPV and IPV,
respectively [9]. In the remote Papua province of
Indonesia, polio vaccination coverage was 68.2% in 2017
and 40.8% in 2018 [10].
Cross-border polio vaccinations: the urgent need in
southeast Asian countries
Cross border cooperation and efforts are needed. The
mapping of less accessible border areas e.g. in Papua
New Guinea and Timor Leste as well as migrant routes
is important. The vaccination should be given by hu-
manitarian groups to stateless children or non-citizens.
It is especially important to maintain coverage of polio
immunization at over 95% in high-risk areas with sea-
sonal migrant populations. Surveillance of vaccination
patterns based on data mining and geo-mapping of mi-
grant and cross-border vaccinations that has proven suc-
cessful in containing polio in Nigeria could be adopted
to optimize the limited vaccine stocks and healthcare
resources.
Conclusion
The health authorities need to increase the inactivated
polio vaccine coverage to prevent further spread of
cVDPV. Doctors should always look out for polio-like
symptoms of acute flaccid paralysis among children by
testing the presence of polio virus or cVDPV in the pa-
tients’ stool samples. Other important precautionary
measure is to test the presence of polio virus or cVDPV
at sewage treatment plants. Application of advanced
analytics and disease transmission model to map out
and estimate seasonal migrant routes and populations
could save time and lives of the vulnerable populations.
Despite of inactivated polio vaccine stock-outs and cost
of polio vaccination, cross-border vaccination at
permanent transit point and surveillance of nomadic
populations would still be cost-effective. The existence
of inadequately vaccinated groups within neighbouring
countries pose a serious threat to reintroduction of the
poliovirus.
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